READNOUR ROBIN SHANE sold 0.2% of their position (1.11K shares) of AN2 THERAPEUTICS, INC. on the open market
Open‑market sale worth $6.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/11/2026ACC: 0001193125-26-389545
Director
Since Mar 2022
-1.11K
Net shares
Net seller
$6.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
1.11K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−523.00
Price / share
$6.02
Trade value
$3.15K
% of position
0.1%
9/9/2026
557.99K→557.47K
Common Stock
Indirect
Shares
−585.00
Price / share
$6.02
Trade value
$3.52K
% of position
0.1%
9/9/2026
625.35K→624.76K
Total
Net shares
−1.11K
Net value
-$6.67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/9/2026 | S · Sale | −523.00 | $6.02 | $3.15K | 0.1% | 557.99K | 557.47K |
| Common Stock Indirect | 9/9/2026 | S · Sale | −585.00 | $6.02 | $3.52K | 0.1% | 625.35K | 624.76K |
| Total | −1.11K | -$6.67K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned9.08K
Total
9.08K direct9.08K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 9.08K | Direct |
| Total | 9.08K | 9.08K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported